INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma - Trial NCT06227299
Access comprehensive clinical trial information for NCT06227299 through Pure Global AI's free database. This phase not specified trial is sponsored by Swiss Glaucoma Research Foundation and is currently Enrolling by invitation. The study focuses on Glaucoma. Target enrollment is 5000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Swiss Glaucoma Research Foundation
Timeline & Enrollment
N/A
May 29, 2018
Jan 01, 2030
Primary Outcome
IOP changes,Number of molecules
Summary
The aim of this study is to create a large-scale register of all glaucoma patients diagnosed,
 followed and treated in a large tertiary centre specialising in glaucoma, in order to analyse
 whether specific factors influence the progression of the disease or guide our choice of
 treatment. This should lead to a better understanding of the disease and the factors to be
 taken into account when choosing the best treatment option for each patient, leading to
 safer, more effective and patient-centred care.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06227299
Non-Device Trial